Is it safe?
Can HAE take a bad year?
Haemonetics Corporation carries $979M of net debt at 3.65× EBITDA: a load its earnings can carry.
$979M
Net debt · as at Q4 2026 · between two and four years of EBITDA, normal for a stable business
- Net debt / EBITDA
- 3.65×
Net debt / EBITDA · 2.72× a year ago · the load is going up
- Altman Z-score
- 2.54
Altman Z-score · grey zone, between 1.8 and 3
- Debt / equity
- 1.54×
Debt / equity
Details›
- Total debtQ4 2026
- $1.22B
- Cash and short-term investments
- $245M
- Net debt
- $979M
- EBITDA, trailing twelve months
- $268M
- Operating profit, trailing twelve months
- $157M
- Debt / equity
- 1.54×
- Total debt / EBITDA
- 4.56×
- Annualised volatilitytwo years of daily moves
- 48%
- Worst drawdown on file
- −69%
- Below its 52-week high
- −2.0%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.